Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gastrointestinal Neoplasms × domatinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Merkel Cell 2 Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Oxaliplatin 9 Capecitabine 8 Cisplatin 7 Fluorouracil 5 Leucovorin 4 Bevacizumab 4 tegafur-gimeracil-oteracil 3 pemigatinib 3 atezolizumab 3 trebananib 2 ponatinib 2 avelumab 2 apatinib 2 alectinib 2 XELOX 2 Standard of Care 2 S 1 (combination) 2 Radiotherapy 2 Radiosurgery 2 Ocoxin 2 Nivolumab 2 Irinotecan 2 Gemcitabine 2 Folfox protocol 2 Everolimus 2 Erlotinib Hydrochloride 2 Acupuncture Therapy 2 zanidatamab 1 ulixertinib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03812796 2019-02-05

EMERGE

Royal Marsden NHS Foundation Trust

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡